Schedule 13G ownership disclosure

TEKMIRA PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 87911B209

Event date: 2015-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,214,800
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-002824
Form type
SC 13G
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Jan 20, 2015
Reporting period
Jan 12, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub